Skip to content

DR.VANDEROOST SOFIE,ALGEMENE GENEESKUNDE: what changed

BE 0807.688.019NACE 86.210, General medical practiceOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€70,127
2024 · €66,383+€3,744
Equity
€390,715
2024 · €360,606+€30,109
Cash
€278,345
2024 · €159,625+€118,720
Balance sheet total
€412,686
2024 · €384,107+€28,579

Largest movements

2024 to 2025
Assets
  • Current investments -€120,806

    no longer reported in 2025 (was €120,806)

  • Cash +€118,720

    up €118,720 (+74.4%), from €159,625 to €278,345

    mainly Current investments (+€120,806) and Net result for the year (+€70,127)

  • Receivables within one year +€43,338

    up €43,338 (+107%), from €40,385 to €83,724

    of which Other amounts receivable: +€43,127

  • Deferred charges and accrued income -€10,439

    down €10,439 (-33.1%), from €31,534 to €21,095

Equity and liabilities
  • Reserves +€30,109

    up €30,109 (+8.3%), from €360,606 to €390,715

  • Accrued charges and deferred income -€10,600

    down €10,600 (-93.9%), from €11,285 to €685

Income statement
  • Depreciation -€6,118

    down €6,118 (-73.2%), from €8,352 to €2,234

  • Financial income -€1,821

    down €1,821 (-37.6%), from €4,839 to €3,018

  • Taxes +€1,246

    up €1,246 (+4.6%), from €27,268 to €28,514

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €66,383
Gross operating margin +€842
Depreciation +€6,118
Other operating charges +€89
Financial income -€1,821
Financial charges -€238
Taxes -€1,246
Result 2025 €70,127
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€34,525
Investment +€120,806
Financing -€36,611
Cash 2024 €159,625
Net result for the year +€70,127
Depreciation +€2,234
Receivables within one year -€43,338
Deferred charges and accrued income +€10,439
Trade debts +€2,855
Tax, wage and social debts +€2,808
Accrued charges and deferred income -€10,600
Current investments +€120,806
Short-term financial debts +€3,407
Contributions, distributions and other -€40,017
Cash 2025 €278,345
brings cash intakes cash out
Every line side by side 43 lines
Line Code 2024 2025 Change %
Total assets 20/58 €384,107 €412,686 +€28,579 +7.4%
Fixed assets 21/28 €6,757 €4,522 -€2,234 -33.1%
Tangible fixed assets 22/27 €6,427 €4,192 -€2,234 -34.8%
Plant, machinery and equipment 23 €562 €284 -€278 -49.5%
Furniture and vehicles 24 €5,865 €3,908 -€1,956 -33.4%
Other tangible fixed assets 26 €0 - =
Financial fixed assets 28 €330 €330 = 0.0%
Current assets 29/58 €377,350 €408,164 +€30,813 +8.2%
Amounts receivable after more than one year 29 €25,000 €25,000 = 0.0%
Other amounts receivable 291 €25,000 €25,000 = 0.0%
Amounts receivable within one year 40/41 €40,385 €83,724 +€43,338 +107%
Trade receivables 40 €39 €250 +€211 +541%
Other amounts receivable 41 €40,346 €83,474 +€43,127 +107%
Current investments 50/53 €120,806 - -€120,806
Cash at bank and in hand 54/58 €159,625 €278,345 +€118,720 +74.4%
Deferred charges and accrued income 490/1 €31,534 €21,095 -€10,439 -33.1%
Total equity and liabilities 10/49 €384,107 €412,686 +€28,579 +7.4%
Equity 10/15 €360,606 €390,715 +€30,109 +8.3%
Reserves 13 €360,606 €390,715 +€30,109 +8.3%
Distributable reserves 133 €360,606 €390,715 +€30,109 +8.3%
Profit (loss) carried forward 14 €0 €0 =
Amounts payable 17/49 €23,501 €21,971 -€1,531 -6.5%
Amounts payable within one year 42/48 €12,217 €21,286 +€9,070 +74.2%
Financial debts 43 €5,081 €8,487 +€3,407 +67.0%
Credit institutions 430/8 €5,081 €8,487 +€3,407 +67.0%
Trade debts 44 €2,963 €5,819 +€2,855 +96.3%
Suppliers 440/4 €2,963 €5,819 +€2,855 +96.3%
Taxes, remuneration and social security 45 €4,173 €6,980 +€2,808 +67.3%
Taxes 450/3 €4,173 €6,980 +€2,808 +67.3%
Other amounts payable 47/48 €0 - =
Accrued charges and deferred income 492/3 €11,285 €685 -€10,600 -93.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €8,352 €2,234 -€6,118 -73.2%
Other operating charges 640/8 €1,321 €1,232 -€89 -6.7%
Gross operating margin 9900 €99,451 €100,292 +€842 +0.8%
Operating profit (loss) 9901 €89,778 €96,826 +€7,048 +7.9%
Financial income 75/76B €4,839 €3,018 -€1,821 -37.6%
Recurring financial income 75 €4,839 €3,018 -€1,821 -37.6%
Financial charges 65/66B €966 €1,204 +€238 +24.6%
Recurring financial charges 65 €966 €1,204 +€238 +24.6%
Profit (loss) for the period before taxes 9903 €93,651 €98,641 +€4,990 +5.3%
Income taxes 67/77 €27,268 €28,514 +€1,246 +4.6%
Profit (loss) for the period 9904 €66,383 €70,127 +€3,744 +5.6%
Profit (loss) for the period to be appropriated 9905 €66,383 €70,127 +€3,744 +5.6%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€427,376 to €520,183

Midpoint €466,045 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Adjusted equity €390,715
Capitalised earnings €464,036 to €649,650
Indication €427,376 to €520,183

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€390,715
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€390,715

Capitalised earnings

net result for the year (9904)
2025
€70,127
2024
€66,383
2023
€58,385
2022
€45,993
2021
€72,719
excluding non-recurring income and charges
€72,914
Average result
€64,965
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€464,036 / €541,375 / €649,650

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 9 November 2026 via checked.be.